CHICAGO, Feb. 5, 2015 /PRNewswire/ — Golub Capital announced today that as Sole Lead-Arranger, Sole Bookrunner and Administrative Agent it provided a GOLD financing and co-investment equity to support the acquisition of Flexan Corporation (“Flexan” or the “Company”) by Linden Capital Partners (“Linden”). GOLD financings are Golub Capital’s One-Loan Debt facilities.
Founded in 1946, Flexan is a leading global manufacturer of high-precision silicone and rubber parts predominately serving the medical device industry. The Company is headquartered in Chicago and operates manufacturing facilities in the greater Chicago area and China. The Company operates two distinct but complementary business units (FMI and Flexan). FMI delivers clean room manufactured silicone molded components for use in class II disposable and implantable class III medical products. Flexan is a custom molder whose expertise in molding difficult geometries and bonding rubber to metal has earned the company the reputation as an innovative problem solver across numerous attractive healthcare niches.
“As a leading contract manufacturer, Flexan has positioned itself to take advantage of OEM’s focus on accelerating product development while streamlining costs, but it is also advantaged within its niche by having established manufacturing capabilities offshore,” said Stefano Robertson, Managing Director and the head of Golub Capital’s healthcare finance team. “With their successful experiences in contract and private label manufacturing, as well as their stable of networked operating executives, Linden is very well positioned to help the Company achieve their growth objectives and we are thrilled to invest in this company alongside of them.”
Michael Farah, a Principal at Linden Capital Partners, said, “Golub provided a financing solution that offered certainty and efficiency to our process. This is the second deal we’ve closed together in the last six months and our fifth overall. We look forward to building on our strong and growing partnership.”
About Golub Capital Middle Market Lending
Golub Capital’s award winning middle market lending team structures financing solutions with hold positions of up to $250 million. The team also underwrites and syndicates senior credit facilities and a proprietary suite of GOLD (one-loan debt) facilities, up to $500 million. Capital has been #1 in 5 out of the past 6 years from 2009 through 3Q 2014 for senior secured loans of up to $100 million for leveraged buyouts (according to Thomson Reuters LPC and internal data; based on number of deals).
Golub Capital is a nationally recognized credit asset manager with over $10 billion of capital under management. Golub Capital has four highly complementary business lines led by exceptional teams of credit professionals: Middle Market Lending, Late Stage Lending, Broadly Syndicated Loans and Opportunistic Credit. Golub Capital’s lending offices are located in Chicago, New York and San Francisco. For more information, please visit the firm’s website at www.golubcapital.com.
About Linden Capital Partners
Linden Capital Partners is Chicago-based private equity firm focused exclusively on leveraged buyouts in the healthcare and life sciences industries. Linden’s strategy is based upon three elements: i) healthcare and life science industry specialization, ii) integrated private equity and operating expertise, and iii) strategic relationships with large corporations. Linden invests in middle market platforms in the medical products, specialty distribution, pharmaceutical, and services segments of healthcare. For more information, please visit the firm’s website at www.lindenllc.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/golub-capital-provides-one-loan-financing-to-support-linden-capitals-acquisition-of-flexan-300031559.html
SOURCE Golub Capital